首页 > 最新文献

Bone最新文献

英文 中文
Phosphate promotes osteogenic differentiation through non-canonical Wnt signaling pathway in human mesenchymal stem cells. 磷酸盐通过非规范Wnt信号通路促进人间充质干细胞成骨分化。
Pub Date : 2022-08-17 DOI: 10.2139/ssrn.4145245
S. Rui, T. Kubota, Y. Ohata, Kenichi Yamamoto, M. Fujiwara, S. Takeyari, K. Ozono
BACKGROUNDPhosphate is indispensable in osteogenesis and mineralization. However, mechanisms by which phosphate enhances osteogenic differentiation are not fully understood. In this study, we studied the effect of phosphate on osteogenic differentiation as well as signaling pathways induced by phosphate in the process.METHODInduced human bone marrow-derived mesenchymal stem cells differentiation into osteoblasts by the change of media containing β-glycerophosphate (GP), 1 mM inorganic phosphate, or 3 mM inorganic phosphate (Pi). The differentiation of osteoblasts was verified by the expression of osteoblast differentiation markers and calcium deposition. RNA sequencing was performed to assess transcriptome in the early stage of osteogenic differentiation.RESULTSOsteogenic differentiation and mineralization were promoted in the 3 mM Pi group compared to those in the GP and 1 mM Pi groups on day 7 of culture. RNA sequencing revealed that the gene expressions involved in osteogenesis and the components in the Wnt signaling pathway was increased in 3 mM Pi group compared with those in the GP on day 7. Analysis with qPCR and Western blot suggested upregulation of components in the non-canonical Wnt signaling pathway, including WNT5b and phosphorylated-c-Jun in the 3 mM Pi group on day 7. WNT11 mRNA expression was increased in the 2 induction groups on day 7. Inhibition of WNT5b by siRNA experiment attenuated the components in non-canonical Wnt signaling expression, including WNT5b, WNT11 and ROR2 mRNA expression and phosphorylated-c-Jun protein expression. In addition, osteogenic differentiation and mineralization were partly decreased in 3 mM Pi group on day 7 by the inhibition of WNT5b.CONCLUSIONPi promoted osteogenic differentiation through the up-regulation of the non-canonical Wnt signaling pathway, including WNT5b, WNT11, p-c-Jun/c-Jun, in the early stage of differentiation. These findings provide a new perspective into the association of Pi and the non-canonical Wnt signaling pathway during osteogenic differentiation.
磷酸盐在成骨和矿化中是不可缺少的。然而,磷酸盐促进成骨分化的机制尚不完全清楚。在本研究中,我们研究了磷酸盐对成骨分化的影响以及在此过程中磷酸盐诱导的信号通路。方法通过改变含有β-甘油磷酸(GP)、1 mM无机磷酸盐或3 mM无机磷酸盐(Pi)的培养基,诱导人骨髓间充质干细胞向成骨细胞分化。成骨细胞分化标志物的表达和钙沉积证实成骨细胞的分化。通过RNA测序来评估成骨分化早期的转录组。结果在培养第7天,与GP和1 mM Pi组相比,3 mM Pi组促进了成骨分化和矿化。RNA测序结果显示,与GP组相比,3 mM Pi组在第7天的成骨相关基因和Wnt信号通路组分的表达增加。qPCR和Western blot分析显示,3 mM Pi组在第7天上调了非规范Wnt信号通路中的成分,包括WNT5b和磷酸化c- jun。在第7天,2个诱导组的WNT11 mRNA表达均升高。siRNA实验抑制WNT5b后,WNT5b、WNT11、ROR2 mRNA表达和磷酸化c- jun蛋白表达等非规范Wnt信号表达组分减弱。此外,3 mM Pi组在第7天通过抑制WNT5b部分抑制成骨分化和矿化。结论pi在分化早期通过上调WNT5b、WNT11、p-c-Jun/c-Jun等非规范Wnt信号通路促进成骨分化。这些发现为研究Pi与成骨分化过程中非规范Wnt信号通路的关联提供了新的视角。
{"title":"Phosphate promotes osteogenic differentiation through non-canonical Wnt signaling pathway in human mesenchymal stem cells.","authors":"S. Rui, T. Kubota, Y. Ohata, Kenichi Yamamoto, M. Fujiwara, S. Takeyari, K. Ozono","doi":"10.2139/ssrn.4145245","DOIUrl":"https://doi.org/10.2139/ssrn.4145245","url":null,"abstract":"BACKGROUND\u0000Phosphate is indispensable in osteogenesis and mineralization. However, mechanisms by which phosphate enhances osteogenic differentiation are not fully understood. In this study, we studied the effect of phosphate on osteogenic differentiation as well as signaling pathways induced by phosphate in the process.\u0000\u0000\u0000METHOD\u0000Induced human bone marrow-derived mesenchymal stem cells differentiation into osteoblasts by the change of media containing β-glycerophosphate (GP), 1 mM inorganic phosphate, or 3 mM inorganic phosphate (Pi). The differentiation of osteoblasts was verified by the expression of osteoblast differentiation markers and calcium deposition. RNA sequencing was performed to assess transcriptome in the early stage of osteogenic differentiation.\u0000\u0000\u0000RESULTS\u0000Osteogenic differentiation and mineralization were promoted in the 3 mM Pi group compared to those in the GP and 1 mM Pi groups on day 7 of culture. RNA sequencing revealed that the gene expressions involved in osteogenesis and the components in the Wnt signaling pathway was increased in 3 mM Pi group compared with those in the GP on day 7. Analysis with qPCR and Western blot suggested upregulation of components in the non-canonical Wnt signaling pathway, including WNT5b and phosphorylated-c-Jun in the 3 mM Pi group on day 7. WNT11 mRNA expression was increased in the 2 induction groups on day 7. Inhibition of WNT5b by siRNA experiment attenuated the components in non-canonical Wnt signaling expression, including WNT5b, WNT11 and ROR2 mRNA expression and phosphorylated-c-Jun protein expression. In addition, osteogenic differentiation and mineralization were partly decreased in 3 mM Pi group on day 7 by the inhibition of WNT5b.\u0000\u0000\u0000CONCLUSION\u0000Pi promoted osteogenic differentiation through the up-regulation of the non-canonical Wnt signaling pathway, including WNT5b, WNT11, p-c-Jun/c-Jun, in the early stage of differentiation. These findings provide a new perspective into the association of Pi and the non-canonical Wnt signaling pathway during osteogenic differentiation.","PeriodicalId":93913,"journal":{"name":"Bone","volume":"1 1","pages":"116525"},"PeriodicalIF":0.0,"publicationDate":"2022-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44031123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Intramembranous bone regeneration in diversity outbred mice is heritable. 异交小鼠的膜内骨再生具有遗传性。
Pub Date : 2022-08-01 DOI: 10.2139/ssrn.4117253
Meghan M. Moran, F. Ko, L. Mesner, G. Calabrese, B. Al-Barghouthi, C. Farber, D. Sumner
There are over one million cases of failed bone repair in the U.S. annually, resulting in substantial patient morbidity and societal costs. Multiple candidate genes affecting bone traits such as bone mineral density have been identified in human subjects and animal models using genome-wide association studies (GWAS). This approach for understanding the genetic factors affecting bone repair is impractical in human subjects but could be performed in a model organism if there is sufficient variability and heritability in the bone regeneration response. Diversity Outbred (DO) mice, which have significant genetic diversity and have been used to examine multiple intact bone traits, would be an excellent possibility. Thus, we sought to evaluate the phenotypic distribution of bone regeneration, sex effects and heritability of intramembranous bone regeneration on day 7 following femoral marrow ablation in 47 12-week old DO mice (23 males, 24 females). Compared to a previous study using 4 inbred mouse strains, we found similar levels of variability in the amount of regenerated bone (coefficient of variation of 86 % v. 88 %) with approximately the same degree of heritability (0.42 v. 0.49). There was a trend toward more bone regeneration in males than females. The amount of regenerated bone was either weakly or not correlated with bone mass at intact sites, suggesting that the genetic factors responsible for bone regeneration and intact bone phenotypes are at least partially independent. In conclusion, we demonstrate that DO mice exhibit variation and heritability of intramembranous bone regeneration that will be suitable for future GWAS.
在美国,每年有超过一百万例骨修复失败的病例,导致大量的患者发病率和社会成本。利用全基因组关联研究(GWAS)在人类受试者和动物模型中发现了影响骨性状(如骨矿物质密度)的多个候选基因。这种理解影响骨修复的遗传因素的方法在人类受试者中是不切实际的,但如果在骨再生反应中有足够的可变性和遗传性,则可以在模式生物中进行。近亲繁殖(DO)小鼠具有显著的遗传多样性,并已被用于检查多个完整的骨骼特征,将是一个很好的可能性。因此,我们试图评估47只12周龄DO小鼠(23只雄性,24只雌性)股骨骨髓消融后第7天骨再生的表型分布、性别效应和遗传力。与先前使用4种近交系小鼠的研究相比,我们发现再生骨量的可变性水平相似(变异系数为86 % vs . 88 %),遗传度大致相同(0.42 vs . 0.49)。男性比女性有更多的骨再生趋势。再生骨的数量与完整部位的骨量或弱或不相关,这表明负责骨再生和完整骨表型的遗传因素至少部分独立。总之,我们证明DO小鼠表现出膜内骨再生的变异和遗传性,这将适合未来的GWAS。
{"title":"Intramembranous bone regeneration in diversity outbred mice is heritable.","authors":"Meghan M. Moran, F. Ko, L. Mesner, G. Calabrese, B. Al-Barghouthi, C. Farber, D. Sumner","doi":"10.2139/ssrn.4117253","DOIUrl":"https://doi.org/10.2139/ssrn.4117253","url":null,"abstract":"There are over one million cases of failed bone repair in the U.S. annually, resulting in substantial patient morbidity and societal costs. Multiple candidate genes affecting bone traits such as bone mineral density have been identified in human subjects and animal models using genome-wide association studies (GWAS). This approach for understanding the genetic factors affecting bone repair is impractical in human subjects but could be performed in a model organism if there is sufficient variability and heritability in the bone regeneration response. Diversity Outbred (DO) mice, which have significant genetic diversity and have been used to examine multiple intact bone traits, would be an excellent possibility. Thus, we sought to evaluate the phenotypic distribution of bone regeneration, sex effects and heritability of intramembranous bone regeneration on day 7 following femoral marrow ablation in 47 12-week old DO mice (23 males, 24 females). Compared to a previous study using 4 inbred mouse strains, we found similar levels of variability in the amount of regenerated bone (coefficient of variation of 86 % v. 88 %) with approximately the same degree of heritability (0.42 v. 0.49). There was a trend toward more bone regeneration in males than females. The amount of regenerated bone was either weakly or not correlated with bone mass at intact sites, suggesting that the genetic factors responsible for bone regeneration and intact bone phenotypes are at least partially independent. In conclusion, we demonstrate that DO mice exhibit variation and heritability of intramembranous bone regeneration that will be suitable for future GWAS.","PeriodicalId":93913,"journal":{"name":"Bone","volume":"1 1","pages":"116524"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44068925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Osteoclast rich osteopetrosis due to defects in TCIRG1 gene. TCIRG1基因缺陷引起的富破骨细胞骨质疏松症。
Pub Date : 2022-08-01 DOI: 10.2139/ssrn.4138979
Valentina Capo, M. Abinun, A. Villa
The discovery that mutations in TCIRG1 (also known as Atp6i) gene are responsible for the majority of autosomal recessive osteopetrosis (ARO) forms in humans heralded a new era for comprehension of this heterogeneous rare bone disease. TCIRG1 gene encodes the a3 subunit, an essential isoform of the vacuolar ATPase proton pump involved in the acidification of the resorption lacuna and in secretory lysosome trafficking. The gene defects lead to inefficient bone resorption by unfunctional osteoclasts which are seen in abundance on bone marrow biopsy, delineating this form of ARO as 'osteoclast-rich'. Patients usually present in early childhood with features of extramedullary haematopoiesis (hepatosplenomegaly, anaemia, thrombocytopenia) due to bone marrow fibrosis, and cranial nerve encroachment (blindness in particular). Impaired gastric calcium uptake due to high pH causes the co-occurrence of rickets, described as "osteopetrorickets". Osteoclast dysfunction leads to early death if untreated and allogeneic haematopoietic stem cell transplantation is the treatment of choice. Combined studies in patients and mouse models carrying spontaneous (the oc/oc mouse) or targeted disruption of Atp6i (TCIRG1) gene have been instrumental for the insight into disease pathogenesis and for the development of novel cellular therapies exploiting gene correction.
TCIRG1(也称为Atp6i)基因突变是人类大多数常染色体隐性遗传性骨病(ARO)的原因,这一发现预示着理解这种异质性罕见骨病的新时代。TCIRG1基因编码a3亚基,这是液泡ATP酶质子泵的一种重要异构体,参与吸收腔隙的酸化和分泌溶酶体的运输。基因缺陷导致非功能性破骨细胞的骨吸收效率低下,在骨髓活检中可以看到大量的破骨细胞,将这种形式的ARO描述为“富含破骨细胞”。患者通常在儿童早期出现骨髓纤维化引起的髓外造血(肝脾肿大、贫血、血小板减少)和颅神经侵犯(尤其是失明)。高pH值导致胃钙摄取受损,导致软骨病的同时发生,被称为“骨质疏松性软骨病”。如果不治疗,破骨细胞功能障碍会导致早期死亡,选择异基因造血干细胞移植治疗。在携带Atp6i(TCIRG1)基因的自发(oc/oc小鼠)或靶向破坏的患者和小鼠模型中进行的联合研究有助于深入了解疾病的发病机制,并有助于开发利用基因校正的新型细胞疗法。
{"title":"Osteoclast rich osteopetrosis due to defects in TCIRG1 gene.","authors":"Valentina Capo, M. Abinun, A. Villa","doi":"10.2139/ssrn.4138979","DOIUrl":"https://doi.org/10.2139/ssrn.4138979","url":null,"abstract":"The discovery that mutations in TCIRG1 (also known as Atp6i) gene are responsible for the majority of autosomal recessive osteopetrosis (ARO) forms in humans heralded a new era for comprehension of this heterogeneous rare bone disease. TCIRG1 gene encodes the a3 subunit, an essential isoform of the vacuolar ATPase proton pump involved in the acidification of the resorption lacuna and in secretory lysosome trafficking. The gene defects lead to inefficient bone resorption by unfunctional osteoclasts which are seen in abundance on bone marrow biopsy, delineating this form of ARO as 'osteoclast-rich'. Patients usually present in early childhood with features of extramedullary haematopoiesis (hepatosplenomegaly, anaemia, thrombocytopenia) due to bone marrow fibrosis, and cranial nerve encroachment (blindness in particular). Impaired gastric calcium uptake due to high pH causes the co-occurrence of rickets, described as \"osteopetrorickets\". Osteoclast dysfunction leads to early death if untreated and allogeneic haematopoietic stem cell transplantation is the treatment of choice. Combined studies in patients and mouse models carrying spontaneous (the oc/oc mouse) or targeted disruption of Atp6i (TCIRG1) gene have been instrumental for the insight into disease pathogenesis and for the development of novel cellular therapies exploiting gene correction.","PeriodicalId":93913,"journal":{"name":"Bone","volume":"1 1","pages":"116519"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42539823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Determinants of muscle density and clinical outcomes: Findings from the Hertfordshire Cohort Study. 肌肉密度和临床结果的决定因素:赫特福德郡队列研究的结果。
Pub Date : 2022-08-01 DOI: 10.2139/ssrn.4108552
F. Laskou, L. Westbury, N. Fuggle, N. Harvey, H. Patel, C. Cooper, K. Ward, E. Dennison
PURPOSEThe age-related loss of skeletal muscle mass and strength is associated with adverse health outcomes. However, to date, peripheral quantitative computed tomography (pQCT)-derived muscle density has been little studied. We used a well characterised cohort of older adults to identify lifestyle and anthropometric determinants of pQCT-derived muscle density measured 11 years later, and to report relationships between pQCT-derived muscle density with history of falls and prevalent fractures.METHODSA lifestyle questionnaire was administered to 197 men and 178 women, aged 59-70 at baseline. After a median of 11.5 (IQR 10.9, 12.3) years, pQCT (Stratec XCT2000) of the radius and tibia was performed to measure forearm muscle density (FMD) and calf muscle density (CMD). Presence of falls and fractures since the age of 45 were determined through participant recall; vertebral fractures were also ascertained through vertebral fracture assessment using iDXA. Total hip BMD (TH aBMD) was assessed using DXA. Baseline characteristics in relation to muscle density at follow-up were examined using linear regression; associations between muscle density and prior falls and fractures were investigated using logistic regression. All analyses were adjusted for sex and age.RESULTSMean (SD) age at muscle density measurement was 76.3 (2.6) years. Mean (SD) FMD was 79.9 (3.1) and 77.2 (3.2) among males and females, respectively; CMD was 80.7 (2.6) and 78.5 (2.6) among males and females, respectively. Significant sex-differences in muscle density were observed at each site (p < 0.001). Female sex, lower weight, and lower body mass index were associated (p < 0.05) with both lower FMD and CMD. Additional correlates of lower CMD included older age and shorter stature. Lifestyle measures were not associated with muscle density in this cohort. Lower FMD was related to increased risk of previous fracture (OR (95 % CI) per SD lower FMD: 1.42 (1.07, 1.89), p = 0.015) but not after adjustment for TH aBMD (p > 0.08). No significant relationships were seen between muscle density and falls.CONCLUSIONFemale sex, older age, and lower BMI were associated with subsequent lower muscle density in older community-dwelling adults. Lower FMD was related to increased risk of previous fracture. Changes in muscle density over time might precede adverse outcomes such as falls and fractures and may be a long-term predictor of frailty. It could be also suggested that muscle density could be a more clinically meaningful surrogate of functional decline and disability than muscle size or mass, but more studies are needed to support this notion.
目的与年龄相关的骨骼肌质量和力量的丧失与不良的健康后果有关。然而,到目前为止,外周定量计算机断层扫描(pQCT)衍生的肌肉密度研究很少。我们使用了一个具有良好特征的老年人队列来确定生活方式和pQCT衍生肌肉密度的人体测量决定因素 几年后,并报告pQCT衍生的肌肉密度与跌倒史和常见骨折之间的关系。方法对197名男性和178名女性进行生活方式问卷调查,基线年龄为59-70岁。中位11.5(IQR 10.9,12.3)年后,对桡骨和胫骨进行pQCT(Stratec XCT2000),以测量前臂肌肉密度(FMD)和小腿肌肉密度(CMD)。通过参与者回忆来确定自45岁以来是否存在跌倒和骨折;还通过使用iDXA的脊椎骨折评估来确定脊椎骨折。使用DXA评估髋关节总骨密度(TH-aBMD)。使用线性回归检查随访时与肌肉密度相关的基线特征;肌肉密度与先前跌倒和骨折之间的关系采用逻辑回归进行研究。所有分析均根据性别和年龄进行了调整。结果肌肉密度测量的平均(SD)年龄为76.3(2.6)岁。男性和女性的平均FMD分别为79.9(3.1)和77.2(3.2);男性和女性的CMD分别为80.7(2.6)和78.5(2.6)。每个部位的肌肉密度存在显著的性别差异(p  0.08)。在肌肉密度和跌倒之间没有发现显著的关系。结论女性、年龄较大、BMI较低与社区老年人随后的肌肉密度较低有关。较低的FMD与先前骨折的风险增加有关。随着时间的推移,肌肉密度的变化可能先于跌倒和骨折等不良结果,并且可能是虚弱的长期预测因素。也有人认为,肌肉密度可能比肌肉大小或质量更能代表功能下降和残疾,但还需要更多的研究来支持这一观点。
{"title":"Determinants of muscle density and clinical outcomes: Findings from the Hertfordshire Cohort Study.","authors":"F. Laskou, L. Westbury, N. Fuggle, N. Harvey, H. Patel, C. Cooper, K. Ward, E. Dennison","doi":"10.2139/ssrn.4108552","DOIUrl":"https://doi.org/10.2139/ssrn.4108552","url":null,"abstract":"PURPOSE\u0000The age-related loss of skeletal muscle mass and strength is associated with adverse health outcomes. However, to date, peripheral quantitative computed tomography (pQCT)-derived muscle density has been little studied. We used a well characterised cohort of older adults to identify lifestyle and anthropometric determinants of pQCT-derived muscle density measured 11 years later, and to report relationships between pQCT-derived muscle density with history of falls and prevalent fractures.\u0000\u0000\u0000METHODS\u0000A lifestyle questionnaire was administered to 197 men and 178 women, aged 59-70 at baseline. After a median of 11.5 (IQR 10.9, 12.3) years, pQCT (Stratec XCT2000) of the radius and tibia was performed to measure forearm muscle density (FMD) and calf muscle density (CMD). Presence of falls and fractures since the age of 45 were determined through participant recall; vertebral fractures were also ascertained through vertebral fracture assessment using iDXA. Total hip BMD (TH aBMD) was assessed using DXA. Baseline characteristics in relation to muscle density at follow-up were examined using linear regression; associations between muscle density and prior falls and fractures were investigated using logistic regression. All analyses were adjusted for sex and age.\u0000\u0000\u0000RESULTS\u0000Mean (SD) age at muscle density measurement was 76.3 (2.6) years. Mean (SD) FMD was 79.9 (3.1) and 77.2 (3.2) among males and females, respectively; CMD was 80.7 (2.6) and 78.5 (2.6) among males and females, respectively. Significant sex-differences in muscle density were observed at each site (p < 0.001). Female sex, lower weight, and lower body mass index were associated (p < 0.05) with both lower FMD and CMD. Additional correlates of lower CMD included older age and shorter stature. Lifestyle measures were not associated with muscle density in this cohort. Lower FMD was related to increased risk of previous fracture (OR (95 % CI) per SD lower FMD: 1.42 (1.07, 1.89), p = 0.015) but not after adjustment for TH aBMD (p > 0.08). No significant relationships were seen between muscle density and falls.\u0000\u0000\u0000CONCLUSION\u0000Female sex, older age, and lower BMI were associated with subsequent lower muscle density in older community-dwelling adults. Lower FMD was related to increased risk of previous fracture. Changes in muscle density over time might precede adverse outcomes such as falls and fractures and may be a long-term predictor of frailty. It could be also suggested that muscle density could be a more clinically meaningful surrogate of functional decline and disability than muscle size or mass, but more studies are needed to support this notion.","PeriodicalId":93913,"journal":{"name":"Bone","volume":"1 1","pages":"116521"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45526461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Osteopetrosis associated with PLEKHM1 and SNX10 genes, both involved in osteoclast vesicular trafficking. 与PLEKHM1和SNX10基因相关的骨质疏松,两者都参与破骨细胞囊泡运输。
Pub Date : 2022-08-01 DOI: 10.2139/ssrn.4137168
Yentl Huybrechts, W. Van Hul
The clinical and radiological variability seen in different forms of osteopetrosis, all due to impaired osteoclastic bone resorption, reflect many causal genes. Both defective differentiation of osteoclasts from hematopoietic stem cells as well as disturbed functioning of osteoclasts can be the underlying pathogenic mechanism. Pathogenic variants in PLEKHM1 and SNX10 can be classified among the latter as they impair vesicular transport within the osteoclast and therefore result in the absence of a ruffled border. Some of the typical radiological hallmarks of osteopetrosis can be seen, and most cases present as a relatively mild form segregating in an autosomal recessive mode of inheritance.
不同形式的骨质疏松症的临床和影像学差异,都是由于破骨细胞骨吸收受损,反映了许多致病基因。破骨细胞从造血干细胞分化的缺陷和破骨细胞功能的紊乱可能是潜在的致病机制。PLEKHM1和SNX10的致病变异可归为后者,因为它们损害破骨细胞内的囊泡运输,因此导致皱褶边界的缺失。可以看到一些典型的骨质疏松的放射学特征,大多数病例表现为相对轻微的常染色体隐性遗传分离。
{"title":"Osteopetrosis associated with PLEKHM1 and SNX10 genes, both involved in osteoclast vesicular trafficking.","authors":"Yentl Huybrechts, W. Van Hul","doi":"10.2139/ssrn.4137168","DOIUrl":"https://doi.org/10.2139/ssrn.4137168","url":null,"abstract":"The clinical and radiological variability seen in different forms of osteopetrosis, all due to impaired osteoclastic bone resorption, reflect many causal genes. Both defective differentiation of osteoclasts from hematopoietic stem cells as well as disturbed functioning of osteoclasts can be the underlying pathogenic mechanism. Pathogenic variants in PLEKHM1 and SNX10 can be classified among the latter as they impair vesicular transport within the osteoclast and therefore result in the absence of a ruffled border. Some of the typical radiological hallmarks of osteopetrosis can be seen, and most cases present as a relatively mild form segregating in an autosomal recessive mode of inheritance.","PeriodicalId":93913,"journal":{"name":"Bone","volume":"1 1","pages":"116520"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47301916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Denosumab treatment is associated with decreased cortical porosity and increased bone density and strength at the proximal humerus of ovariectomized cynomolgus monkeys. Denosumab治疗与切除卵巢的食蟹猴肱骨近端皮质孔隙率降低、骨密度和强度增加有关。
Pub Date : 2022-08-01 DOI: 10.2139/ssrn.4045829
I. Haider, A. Sawatsky, Ying Zhu, Rebecca Page, P. Kostenuik, S. Boyd, W. B. Edwards
Upper extremity fractures, including those at the humerus, are common among women with postmenopausal osteoporosis. Denosumab was shown to reduce humeral fractures in this population; however, no clinical or preclinical studies have quantified the effects of denosumab on humerus bone mineral density or bone microarchitecture changes. This study used micro-computed tomography (μCT) and computed tomography (CT), alongside image-based finite element (FE) models derived from both modalities, to quantify the effects of denosomab (DMAb) and alendronate (ALN) on humeral bone from acutely ovariectomized (OVX) cynomolgus monkeys. Animals were treated with 12 monthly injections of s.c. vehicle (VEH; n = 10), s.c. denosumab (DMAb; 25 mg/kg, n = 9), or i.v. alendronate (ALN; 50 μg/kg, n = 10). Two more groups received 6 months of VEH followed by 6 months of DMAb (VEH-DMAb; n = 7) or 6 months of ALN followed by 6 months of DMAb (ALN-DMAb; n = 9). After treatment, humeri were harvested and μCT was used to quantify tissue mineral density, trabecular morphology, and cortical porosity at the humeral head. Clinical CT imaging was also used to quantify trabecular and cortical bone mineral density (BMD) at the ultra-proximal, proximal, 1/5 proximal and midshaft of the bone. Finally, μCT-based FE models in compression, and CT-based FE models in compression, torsion, and bending, were developed to estimate differences in strength. Compared to VEH, groups that received DMAb at any time demonstrated lower cortical porosity and/or higher tissue mineral density via μCT; no effects on trabecular morphology were observed. FE estimated strength based on μCT was higher after 12-months DMAb (p = 0.020) and ALN-DMAb (p = 0.024) vs. VEH; respectively, FE predicted mean (SD) strength was 4649.88 (710.58) N, and 4621.10 (1050.16) N vs. 3309.4 (876.09) N. All antiresorptive treatments were associated with higher cortical BMD via CT at the 1/5 proximal and midshaft of the humerus; however, no differences in CT-based FE predicted strength were observed. Overall, these results help to explain the observed reductions in humeral fracture rate following DMAb treatment in women with postmenopausal osteoporosis.
上肢骨折,包括肱骨骨折,在绝经后骨质疏松症妇女中很常见。Denosumab被证明可以减少该人群的肱骨骨折;然而,没有临床或临床前研究量化狄诺沙单抗对肱骨骨密度或骨微结构变化的影响。这项研究使用了微型计算机断层扫描(μCT)和计算机断层成像(CT),以及从这两种模式衍生的基于图像的有限元(FE)模型,来量化脱诺索单抗(DMAb)和阿仑膦酸盐(ALN)对急性去卵巢(OVX)食蟹猴肱骨的影响。动物接受12个月一次的皮下注射载体(VEH;n = 10) ,皮下注射狄诺沙单抗(DMAb;25 mg/kg,n = 9) ,或静脉注射阿仑膦酸盐(ALN;50 μg/kg,n = 10) 。另外两组收到6 VEH后6个月 DMAb的月数(VEH DMAb;n = 7) 或6 ALN数月后6个月 DMAb的月数(ALN DMAb;n = 9) 。治疗后,采集肱骨,并使用μCT量化肱骨头的组织矿物密度、小梁形态和皮质孔隙度。临床CT成像也用于量化骨的超近端、近端、1/5近端和中段的骨小梁和皮质骨密度(BMD)。最后,开发了基于μCT的压缩有限元模型,以及基于CT的压缩、扭转和弯曲有限元模型来估计强度差异。与VEH相比,在任何时间接受DMAb的组通过μCT表现出较低的皮层孔隙率和/或较高的组织矿物密度;未观察到对小梁形态的影响。基于μCT的FE估计强度在DMAb治疗12个月后更高(p = 0.020)和ALN-DMAb(p = 0.024)对VEH;FE预测的平均(SD)强度分别为4649.88(710.58)N和4621.10(1050.16)N,而不是3309.4(876.09)N。通过CT检查,所有抗再吸收治疗都与肱骨近端和中段皮质骨密度较高有关;然而,在基于CT的FE预测强度方面没有观察到差异。总的来说,这些结果有助于解释DMAb治疗绝经后骨质疏松症妇女后观察到的肱骨骨折率降低。
{"title":"Denosumab treatment is associated with decreased cortical porosity and increased bone density and strength at the proximal humerus of ovariectomized cynomolgus monkeys.","authors":"I. Haider, A. Sawatsky, Ying Zhu, Rebecca Page, P. Kostenuik, S. Boyd, W. B. Edwards","doi":"10.2139/ssrn.4045829","DOIUrl":"https://doi.org/10.2139/ssrn.4045829","url":null,"abstract":"Upper extremity fractures, including those at the humerus, are common among women with postmenopausal osteoporosis. Denosumab was shown to reduce humeral fractures in this population; however, no clinical or preclinical studies have quantified the effects of denosumab on humerus bone mineral density or bone microarchitecture changes. This study used micro-computed tomography (μCT) and computed tomography (CT), alongside image-based finite element (FE) models derived from both modalities, to quantify the effects of denosomab (DMAb) and alendronate (ALN) on humeral bone from acutely ovariectomized (OVX) cynomolgus monkeys. Animals were treated with 12 monthly injections of s.c. vehicle (VEH; n = 10), s.c. denosumab (DMAb; 25 mg/kg, n = 9), or i.v. alendronate (ALN; 50 μg/kg, n = 10). Two more groups received 6 months of VEH followed by 6 months of DMAb (VEH-DMAb; n = 7) or 6 months of ALN followed by 6 months of DMAb (ALN-DMAb; n = 9). After treatment, humeri were harvested and μCT was used to quantify tissue mineral density, trabecular morphology, and cortical porosity at the humeral head. Clinical CT imaging was also used to quantify trabecular and cortical bone mineral density (BMD) at the ultra-proximal, proximal, 1/5 proximal and midshaft of the bone. Finally, μCT-based FE models in compression, and CT-based FE models in compression, torsion, and bending, were developed to estimate differences in strength. Compared to VEH, groups that received DMAb at any time demonstrated lower cortical porosity and/or higher tissue mineral density via μCT; no effects on trabecular morphology were observed. FE estimated strength based on μCT was higher after 12-months DMAb (p = 0.020) and ALN-DMAb (p = 0.024) vs. VEH; respectively, FE predicted mean (SD) strength was 4649.88 (710.58) N, and 4621.10 (1050.16) N vs. 3309.4 (876.09) N. All antiresorptive treatments were associated with higher cortical BMD via CT at the 1/5 proximal and midshaft of the humerus; however, no differences in CT-based FE predicted strength were observed. Overall, these results help to explain the observed reductions in humeral fracture rate following DMAb treatment in women with postmenopausal osteoporosis.","PeriodicalId":93913,"journal":{"name":"Bone","volume":"1 1","pages":"116517"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47837907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of zoledronate on bone mineral density and bone turnover after long-term denosumab therapy: Observations in a real-world setting. 唑来膦酸钠对长期地诺单抗治疗后骨密度和骨转换的影响:在现实世界环境中的观察。
Pub Date : 2022-07-01 DOI: 10.2139/ssrn.4106277
J. Everts‐Graber, S. Reichenbach, B. Gahl, H. Häuselmann, H. Ziswiler, U. Studer, Thomas Lehmann
BACKGROUNDThe rebound effect after denosumab discontinuation is lessened with subsequent zoledronate therapy. However, it is unclear whether this mitigation is sufficient after long-term denosumab treatment.OBJECTIVEThis retrospective observational study analysed bone mineral density (BMD) and bone turnover marker (BTM) changes after denosumab therapy according to treatment duration and subsequent zoledronate regimen.METHODSWe measured the outcomes of 282 women with postmenopausal osteoporosis who discontinued denosumab and received zoledronate 6 months later. In patients with longer denosumab therapy (≥5 years), BTMs were measured every 3 months and a second zoledronate infusion was administered if BTM levels increased by ≥2-fold. The BMD of all women was measured before denosumab therapy, at the last injection and 1 to 2 years after the first zoledronate.RESULTSBone loss after switching from denosumab to zoledronate was higher in patients with 10 ± 2 denosumab injections (n = 84) compared to 5 ± 2 injections (n = 144, p < 0.001 for lumbar spine and femoral neck), but there was no further increase with treatment durations of ≥15 ± 2 injections (n = 54, p = 0.35 and p = 0.20, respectively). BTMs in patients with ≥10 denosumab injections were elevated 6 months after zoledronate in some patients, but not all. Twenty-four women received a second zoledronate dose 6 months after the first one. BTMs in these patients were subsequently lower, but bone loss at both the lumbar spine and hip was comparable to that in patients with only one zoledronate dose (p = 0.37 for lumbar spine and p = 0.97 for femoral neck).CONCLUSIONSRebound-associated bone loss reached a plateau after denosumab treatment durations of 4-6 years, irrespective of the frequency of subsequent zoledronate therapy.
背景停药后的反弹作用随着唑来膦酸盐的治疗而减轻。然而,目前尚不清楚这种缓解在长期使用狄诺沙单抗治疗后是否足够。目的本回顾性观察性研究根据治疗时间和随后的唑来膦酸盐方案,分析了去诺沙单抗治疗后骨密度(BMD)和骨转换标志物(BTM)的变化。方法我们测量了282名绝经后骨质疏松症妇女的结果,这些妇女停用了替诺沙单抗并接受了唑来膦酸酯6 几个月后。在长期使用狄诺沙单抗治疗的患者中(≥5 年),BTM每3次测量 月,如果BTM水平增加≥2倍,则给予第二次唑来膦酸盐输注。所有女性的骨密度在denosumab治疗前、最后一次注射时和1至2次注射时进行测量 在第一个唑来膦酸酯之后的几年。结果10岁患者从替诺沙单抗转为唑来膦酸盐后的酮损失更高 ± 2次注射狄诺沙单抗(n = 84)相比之下为5 ± 2次注射(n = 144,p < 腰椎和股骨颈0.001),但随着治疗持续时间≥15,没有进一步增加 ± 2次注射(n = 54,p = 0.35和p = 0.20)。注射狄诺沙单抗≥10次的患者BTMs升高6 唑来膦酸盐治疗后数月,但并非全部。24名妇女接受了第二剂唑来膦酸盐6 第一个月后。这些患者的BTMs随后降低,但腰椎和髋关节的骨丢失与仅服用一剂唑来膦酸盐的患者相当(p = 腰椎0.37,p = 股骨颈0.97) 年,无论随后唑来膦酸盐治疗的频率如何。
{"title":"Effects of zoledronate on bone mineral density and bone turnover after long-term denosumab therapy: Observations in a real-world setting.","authors":"J. Everts‐Graber, S. Reichenbach, B. Gahl, H. Häuselmann, H. Ziswiler, U. Studer, Thomas Lehmann","doi":"10.2139/ssrn.4106277","DOIUrl":"https://doi.org/10.2139/ssrn.4106277","url":null,"abstract":"BACKGROUND\u0000The rebound effect after denosumab discontinuation is lessened with subsequent zoledronate therapy. However, it is unclear whether this mitigation is sufficient after long-term denosumab treatment.\u0000\u0000\u0000OBJECTIVE\u0000This retrospective observational study analysed bone mineral density (BMD) and bone turnover marker (BTM) changes after denosumab therapy according to treatment duration and subsequent zoledronate regimen.\u0000\u0000\u0000METHODS\u0000We measured the outcomes of 282 women with postmenopausal osteoporosis who discontinued denosumab and received zoledronate 6 months later. In patients with longer denosumab therapy (≥5 years), BTMs were measured every 3 months and a second zoledronate infusion was administered if BTM levels increased by ≥2-fold. The BMD of all women was measured before denosumab therapy, at the last injection and 1 to 2 years after the first zoledronate.\u0000\u0000\u0000RESULTS\u0000Bone loss after switching from denosumab to zoledronate was higher in patients with 10 ± 2 denosumab injections (n = 84) compared to 5 ± 2 injections (n = 144, p < 0.001 for lumbar spine and femoral neck), but there was no further increase with treatment durations of ≥15 ± 2 injections (n = 54, p = 0.35 and p = 0.20, respectively). BTMs in patients with ≥10 denosumab injections were elevated 6 months after zoledronate in some patients, but not all. Twenty-four women received a second zoledronate dose 6 months after the first one. BTMs in these patients were subsequently lower, but bone loss at both the lumbar spine and hip was comparable to that in patients with only one zoledronate dose (p = 0.37 for lumbar spine and p = 0.97 for femoral neck).\u0000\u0000\u0000CONCLUSIONS\u0000Rebound-associated bone loss reached a plateau after denosumab treatment durations of 4-6 years, irrespective of the frequency of subsequent zoledronate therapy.","PeriodicalId":93913,"journal":{"name":"Bone","volume":"1 1","pages":"116498"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42365535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Cellular and Molecular Mechanism of Cell Proliferation in Human Gastric Cancer Drug-Resistant Cells After Hyperthermia and Cisplatin: Role of mRNAs and Long-Non-coding RNAs. 高热和顺铂作用下人胃癌耐药细胞增殖的细胞和分子机制:mRNA 和长非编码 RNA 的作用。
IF 1.2 Pub Date : 2022-05-01 DOI: 10.5152/tjg.2022.20845
Firoozeh Abolhasani Zadeh, Mina AkbariRad, HuoJun Lian, Ying Wei, Jing Yang, Xiaoke Feng, Reza Akhavan-Sigari

Background: Since thermo-chemotherapy was suggested as an effective treatment for gastric cancer, we aimed to evaluate the effects of hyperthermia combined with cisplatin (DDP) on the inhibition of human gastric cancer drug-resistant cells in vitro and explore its possible mechanisms.

Methods: SGC-7901/DDP cells were cultured and divided into control, cisplatin, hyperthermia, and hyperthermia combined with cispla- tin groups. Hyperthermia was done at 42°C, 44°C, 46°C, 48°C, and 50°C for 12 h, 24 h, 36 h; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl- 2H-tetrazolium bromide (MTT) assay detected the proliferation of SGC-7901/DDP at different time and temperature, and the apoptotic rate of SGC-7901/DDP cells was evaluated by using Annexin staining assay. High-throughput Chromatin immunoprecipitation (ChIP)- seq was applied to test long non-coding RNA expression in SGC-7901/DDP cells. Then, real-time fluorescence quantitative polymerase chain reaction was used to verify the expression of long non-coding RNA in all groups.

Results: Double staining showed that hyperthermia combined with cisplatin increased the rate of early apoptosis of SGC-7901/DDP cells. Long non-coding RNA high-throughput ChIP-seq showed a significantly larger amount of long non-coding RNAs and mRNAs in the cells treated with hyperthermia combined cisplatin group in comparison with the control group. We observed that the upregulated mRNAs and long non-coding RNAs were highly related to immune system response and CD95 signaling pathway in nucleus, and down- regulated mRNAs and long non-coding RNA were highly related to Mammalian target of rapamycin (mTOR) and Tumor necrosis factor (TNF) receptor signaling pathway in cytoplasm.

Conclusion: Hyperthermia combined with cisplatin reversed the expression of a large number of mRNAs and long non-coding RNAs in human gastric cancer drug-resistant cells. The molecular mechanism of inhibiting the proliferation of human gastric cancer drug- resistant cells may be related to the upregulation of long non-coding RNAs and mRNAs contributed in CD95, mTOR, and TNF receptor signaling pathway.

背景:由于热化疗被认为是治疗胃癌的一种有效方法,我们旨在评估热化疗联合顺铂(DDP)在体外对人胃癌耐药细胞的抑制作用,并探讨其可能的机制:方法:培养 SGC-7901/DDP 细胞,将其分为对照组、顺铂组、热疗组和热疗联合顺铂组。热疗温度分别为42℃、44℃、46℃、48℃和50℃,时间分别为12小时、24小时和36小时;3-(4,5-二甲基噻唑-2-基)-2,5-二苯基- 2H-溴化四氮唑(MTT)检测不同时间和温度下SGC-7901/DDP细胞的增殖情况,Annexin染色检测SGC-7901/DDP细胞的凋亡率。应用高通量染色质免疫沉淀(ChIP)- seq检测SGC-7901/DDP细胞中长非编码RNA的表达。然后,采用实时荧光定量聚合酶链反应来验证各组长非编码 RNA 的表达:结果:双重染色显示,热疗联合顺铂增加了 SGC-7901/DDP 细胞的早期凋亡率。长非编码 RNA 高通量 ChIP-seq 结果显示,与对照组相比,热疗联合顺铂治疗组细胞中的长非编码 RNA 和 mRNA 数量明显增加。我们观察到,上调的mRNA和长非编码RNA与细胞核中的免疫系统反应和CD95信号通路高度相关,而下调的mRNA和长非编码RNA与细胞质中的哺乳动物雷帕霉素靶标(mTOR)和肿瘤坏死因子(TNF)受体信号通路高度相关:结论:热疗联合顺铂可逆转人胃癌耐药细胞中大量mRNA和长非编码RNA的表达。抑制人胃癌耐药细胞增殖的分子机制可能与CD95、mTOR和TNF受体信号通路中长非编码RNA和mRNA的上调有关。
{"title":"Cellular and Molecular Mechanism of Cell Proliferation in Human Gastric Cancer Drug-Resistant Cells After Hyperthermia and Cisplatin: Role of mRNAs and Long-Non-coding RNAs.","authors":"Firoozeh Abolhasani Zadeh, Mina AkbariRad, HuoJun Lian, Ying Wei, Jing Yang, Xiaoke Feng, Reza Akhavan-Sigari","doi":"10.5152/tjg.2022.20845","DOIUrl":"10.5152/tjg.2022.20845","url":null,"abstract":"<p><strong>Background: </strong>Since thermo-chemotherapy was suggested as an effective treatment for gastric cancer, we aimed to evaluate the effects of hyperthermia combined with cisplatin (DDP) on the inhibition of human gastric cancer drug-resistant cells in vitro and explore its possible mechanisms.</p><p><strong>Methods: </strong>SGC-7901/DDP cells were cultured and divided into control, cisplatin, hyperthermia, and hyperthermia combined with cispla- tin groups. Hyperthermia was done at 42°C, 44°C, 46°C, 48°C, and 50°C for 12 h, 24 h, 36 h; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl- 2H-tetrazolium bromide (MTT) assay detected the proliferation of SGC-7901/DDP at different time and temperature, and the apoptotic rate of SGC-7901/DDP cells was evaluated by using Annexin staining assay. High-throughput Chromatin immunoprecipitation (ChIP)- seq was applied to test long non-coding RNA expression in SGC-7901/DDP cells. Then, real-time fluorescence quantitative polymerase chain reaction was used to verify the expression of long non-coding RNA in all groups.</p><p><strong>Results: </strong>Double staining showed that hyperthermia combined with cisplatin increased the rate of early apoptosis of SGC-7901/DDP cells. Long non-coding RNA high-throughput ChIP-seq showed a significantly larger amount of long non-coding RNAs and mRNAs in the cells treated with hyperthermia combined cisplatin group in comparison with the control group. We observed that the upregulated mRNAs and long non-coding RNAs were highly related to immune system response and CD95 signaling pathway in nucleus, and down- regulated mRNAs and long non-coding RNA were highly related to Mammalian target of rapamycin (mTOR) and Tumor necrosis factor (TNF) receptor signaling pathway in cytoplasm.</p><p><strong>Conclusion: </strong>Hyperthermia combined with cisplatin reversed the expression of a large number of mRNAs and long non-coding RNAs in human gastric cancer drug-resistant cells. The molecular mechanism of inhibiting the proliferation of human gastric cancer drug- resistant cells may be related to the upregulation of long non-coding RNAs and mRNAs contributed in CD95, mTOR, and TNF receptor signaling pathway.</p>","PeriodicalId":93913,"journal":{"name":"Bone","volume":"50 1","pages":"377-386"},"PeriodicalIF":1.2,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11158417/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75826060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep learning techniques to classify agricultural crops through UAV imagery: a review. 通过无人机图像对农作物进行分类的深度学习技术:综述。
IF 4.5 Pub Date : 2022-01-01 Epub Date: 2022-03-05 DOI: 10.1007/s00521-022-07104-9
Abdelmalek Bouguettaya, Hafed Zarzour, Ahmed Kechida, Amine Mohammed Taberkit

During the last few years, Unmanned Aerial Vehicles (UAVs) technologies are widely used to improve agriculture productivity while reducing drudgery, inspection time, and crop management cost. Moreover, they are able to cover large areas in a matter of a few minutes. Due to the impressive technological advancement, UAV-based remote sensing technologies are increasingly used to collect valuable data that could be used to achieve many precision agriculture applications, including crop/plant classification. In order to process these data accurately, we need powerful tools and algorithms such as Deep Learning approaches. Recently, Convolutional Neural Network (CNN) has emerged as a powerful tool for image processing tasks achieving remarkable results making it the state-of-the-art technique for vision applications. In the present study, we reviewed the recent CNN-based methods applied to the UAV-based remote sensing image analysis for crop/plant classification to help researchers and farmers to decide what algorithms they should use accordingly to their studied crops and the used hardware. Fusing different UAV-based data and deep learning approaches have emerged as a powerful tool to classify different crop types accurately. The readers of the present review could acquire the most challenging issues facing researchers to classify different crop types from UAV imagery and their potential solutions to improve the performance of deep learning-based algorithms.

在过去几年里,无人驾驶飞行器(UAV)技术被广泛应用于提高农业生产率,同时减少繁重的劳动、检查时间和作物管理成本。此外,它们还能在几分钟内覆盖大片区域。由于技术进步显著,基于无人机的遥感技术越来越多地用于收集有价值的数据,这些数据可用于实现许多精准农业应用,包括作物/植物分类。为了准确处理这些数据,我们需要强大的工具和算法,如深度学习方法。最近,卷积神经网络(CNN)已成为图像处理任务的强大工具,取得了令人瞩目的成果,成为视觉应用领域最先进的技术。在本研究中,我们回顾了最近应用于基于无人机的作物/植物分类遥感图像分析的基于卷积神经网络的方法,以帮助研究人员和农民根据他们研究的作物和使用的硬件来决定应该使用哪种算法。融合不同的无人机数据和深度学习方法已成为准确分类不同作物类型的有力工具。通过本综述,读者可以了解研究人员在利用无人机图像对不同作物类型进行分类时所面临的最具挑战性的问题,以及提高基于深度学习的算法性能的潜在解决方案。
{"title":"Deep learning techniques to classify agricultural crops through UAV imagery: a review.","authors":"Abdelmalek Bouguettaya, Hafed Zarzour, Ahmed Kechida, Amine Mohammed Taberkit","doi":"10.1007/s00521-022-07104-9","DOIUrl":"10.1007/s00521-022-07104-9","url":null,"abstract":"<p><p>During the last few years, Unmanned Aerial Vehicles (UAVs) technologies are widely used to improve agriculture productivity while reducing drudgery, inspection time, and crop management cost. Moreover, they are able to cover large areas in a matter of a few minutes. Due to the impressive technological advancement, UAV-based remote sensing technologies are increasingly used to collect valuable data that could be used to achieve many precision agriculture applications, including crop/plant classification. In order to process these data accurately, we need powerful tools and algorithms such as Deep Learning approaches. Recently, Convolutional Neural Network (CNN) has emerged as a powerful tool for image processing tasks achieving remarkable results making it the state-of-the-art technique for vision applications. In the present study, we reviewed the recent CNN-based methods applied to the UAV-based remote sensing image analysis for crop/plant classification to help researchers and farmers to decide what algorithms they should use accordingly to their studied crops and the used hardware. Fusing different UAV-based data and deep learning approaches have emerged as a powerful tool to classify different crop types accurately. The readers of the present review could acquire the most challenging issues facing researchers to classify different crop types from UAV imagery and their potential solutions to improve the performance of deep learning-based algorithms.</p>","PeriodicalId":93913,"journal":{"name":"Bone","volume":"83 1","pages":"9511-9536"},"PeriodicalIF":4.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898032/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75838235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Large-scale osteocyte lacunar morphological analysis of transiliac bone in normal and osteoporotic premenopausal women 绝经前正常和骨质疏松妇女髂骨的骨细胞腔隙形态分析
Pub Date : 2021-12-14 DOI: 10.1101/2021.12.13.21267731
Elliott Goff, A. Cohen, E. Shane, R. Recker, G. Kuhn, R. Müller
Bone's adaptation ability is governed by the network of embedded osteocytes that inhabit individual crevasses called lacunae. The morphology of these lacunae and their resident osteocytes are known to change with age and diseases such as postmenopausal osteoporosis. However, it is unclear whether alterations in lacunar morphology are present in younger populations with osteoporosis. To investigate this, we implemented a previously validated methodology to image and quantify the three-dimensional morphometries of lacunae on a large scale (26.2 million cells) with ultra-high-resolution micro-computed tomography (microCT) in transiliac bone biopsies from three groups of premenopausal women: control n=39; idiopathic osteoporosis (IOP) n=45; idiopathic low BMD (ILBMD) n=19. Important lacunar morphometric parameters were measured in both trabecular and cortical bone: lacunar density (Lc.N/BV), lacunar porosity (Lc.TV/BV), lacunar number (Lc.N), lacunar volume (Lc.V), lacunar surface area (Lc.S), lacunar alignment (Lc.{theta}), lacunar stretch (Lc.St), lacunar oblateness (Lc.Ob), lacunar equancy (Lc.Eq), and lacunar sphericity (Lc.Sr). These were then compared against each other and also with previously measured tissue morphometries including: bone volume density (BV/TV), trabecular separation (Tb.Sp), trabecular number (Tb.N), and trabecular thickness (Tb.Th), structure model index (SMI), cortical porosity (Ct.Po) and cortical pore spacing (Ct.Sp). We detected no differences in lacunar morphology between the IOP, ILBMD and healthy premenopausal women. In contrast, we did find significant differences between lacunar morphologies in cortical and trabecular regions within all three groups, which was consistent with our previous findings on a subgroup of the healthy group. Furthermore, we discovered strong correlations between Lc.Sr from both trabecular and cortical regions with the measured BV/TV. The findings and comprehensive lacunar dataset we present here will be a crucial foundation for future investigations of the relationship between osteocyte lacunar morphology and disease.
骨的适应能力是由嵌入的骨细胞网络控制的,这些骨细胞居住在称为骨陷窝的单个裂缝中。这些腔隙及其骨细胞的形态会随着年龄和疾病(如绝经后骨质疏松症)而改变。然而,尚不清楚腔隙形态的改变是否存在于年轻骨质疏松症人群中。为了研究这一点,我们采用了一种先前经过验证的方法,利用超高分辨率显微计算机断层扫描(microCT)对三组绝经前妇女的经髂骨活检进行了大规模(2620万个细胞)的腔隙三维形态成像和量化:对照组n=39;特发性骨质疏松症(IOP) n=45;特发性低骨密度(ILBMD) n=19。测量骨小梁和骨皮质的重要腔隙形态测量参数:腔隙密度(Lc. n /BV)、腔隙孔隙度(Lc. tv /BV)、腔隙数量(Lc. n)、腔隙体积(Lc. v)、腔隙表面积(Lc. s)、腔隙对准度(Lc.{θ})、腔隙拉伸度(Lc. st)、腔隙平坦度(Lc. ob)、腔隙等距(Lc. eq)和腔隙球形度(Lc. sr)。然后将这些数据相互比较,并与先前测量的组织形态测量进行比较,包括:骨体积密度(BV/TV)、小梁分离(Tb.Sp)、小梁数量(Tb.N)和小梁厚度(Tb.Th)、结构模型指数(SMI)、皮质孔隙度(Ct.Po)和皮质孔隙间距(Ct.Sp)。我们在IOP、ILBMD和健康绝经前妇女之间没有发现腔隙形态的差异。相比之下,我们确实发现在所有三组中,皮层和小梁区域的腔隙形态存在显著差异,这与我们之前在健康组亚组中的发现一致。此外,我们发现Lc。小梁和皮质区的Sr与测量的BV/TV。我们在这里提出的研究结果和全面的腔隙数据集将为未来研究骨细胞腔隙形态与疾病之间的关系奠定重要的基础。
{"title":"Large-scale osteocyte lacunar morphological analysis of transiliac bone in normal and osteoporotic premenopausal women","authors":"Elliott Goff, A. Cohen, E. Shane, R. Recker, G. Kuhn, R. Müller","doi":"10.1101/2021.12.13.21267731","DOIUrl":"https://doi.org/10.1101/2021.12.13.21267731","url":null,"abstract":"Bone's adaptation ability is governed by the network of embedded osteocytes that inhabit individual crevasses called lacunae. The morphology of these lacunae and their resident osteocytes are known to change with age and diseases such as postmenopausal osteoporosis. However, it is unclear whether alterations in lacunar morphology are present in younger populations with osteoporosis. To investigate this, we implemented a previously validated methodology to image and quantify the three-dimensional morphometries of lacunae on a large scale (26.2 million cells) with ultra-high-resolution micro-computed tomography (microCT) in transiliac bone biopsies from three groups of premenopausal women: control n=39; idiopathic osteoporosis (IOP) n=45; idiopathic low BMD (ILBMD) n=19. Important lacunar morphometric parameters were measured in both trabecular and cortical bone: lacunar density (Lc.N/BV), lacunar porosity (Lc.TV/BV), lacunar number (Lc.N), lacunar volume (Lc.V), lacunar surface area (Lc.S), lacunar alignment (Lc.{theta}), lacunar stretch (Lc.St), lacunar oblateness (Lc.Ob), lacunar equancy (Lc.Eq), and lacunar sphericity (Lc.Sr). These were then compared against each other and also with previously measured tissue morphometries including: bone volume density (BV/TV), trabecular separation (Tb.Sp), trabecular number (Tb.N), and trabecular thickness (Tb.Th), structure model index (SMI), cortical porosity (Ct.Po) and cortical pore spacing (Ct.Sp). We detected no differences in lacunar morphology between the IOP, ILBMD and healthy premenopausal women. In contrast, we did find significant differences between lacunar morphologies in cortical and trabecular regions within all three groups, which was consistent with our previous findings on a subgroup of the healthy group. Furthermore, we discovered strong correlations between Lc.Sr from both trabecular and cortical regions with the measured BV/TV. The findings and comprehensive lacunar dataset we present here will be a crucial foundation for future investigations of the relationship between osteocyte lacunar morphology and disease.","PeriodicalId":93913,"journal":{"name":"Bone","volume":"1 1","pages":"116424"},"PeriodicalIF":0.0,"publicationDate":"2021-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44693486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
期刊
Bone
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1